Skip to content
Life Sciences Series B Founded 2015

Safford Decoding

Provider of genetic analysis and precision medicine services. The tests reports enable the clinicians to offer treatment plans as per the individual's genetic profile. The company is developing a genetic analysis platform for gene-related data. Clinical needs provide clinicians with an accurate basis for diagnosis and treatment, thereby enhancing their clinical benefit. The company was founded in 2015 and…

📍 Beijing, China · Genomics,

Funding snapshot

Last roundSeries B
Amount$16M
Date11 May 2021
Total raised$26M
Team size9

About

Provider of genetic analysis and precision medicine services. The tests reports enable the clinicians to offer treatment plans as per the individual's genetic profile. The company is developing a genetic analysis platform for gene-related data. Clinical needs provide clinicians with an accurate basis for diagnosis and treatment, thereby enhancing their clinical benefit. The company was founded in 2015 and headquartered in Beijing, China. It has raised $25.6M in series b funding, with backing from Shenzhen Guozhong Venture Capital Management, Langmafeng Venture Capital, Shengwan Investment-SOVA CAPITAL, Shuimu Venture Capital, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Clinical Genomics space.

Business model

Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Precision Medicine

Institutional investors

Shenzhen Guozhong Venture Capital Management Langmafeng Venture Capital Shengwan Investment-SOVA CAPITAL Shuimu Venture Capital TusStar CS Capital Jiangmen Ventures

Latest coverage

No articles yet.

Raising like Safford Decoding?

Analyze your pitch deck before your next raise.

Analyze My Deck →